| Intestinal epithelial toll-like receptor 4 signaling affects epithelial function and colonic microbiota and promotes a risk for transmissible colitis R Dheer, R Santaolalla, JM Davies, JK Lang, MC Phillips, C Pastorini, ... Infection and immunity 84 (3), 798-810, 2016 | 162 | 2016 |
| Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance V Barbier, J Erbani, C Fiveash, JM Davies, J Tay, MR Tallack, J Lowe, ... Nature communications 11 (1), 2042, 2020 | 159 | 2020 |
| TLR4 activates the β-catenin pathway to cause intestinal neoplasia R Santaolalla, DA Sussman, JR Ruiz, JM Davies, C Pastorini, CL Espana, ... PloS one 8 (5), e63298, 2013 | 132 | 2013 |
| The innate immune system and inflammatory bowel disease JM Davies, MT Abreu Scandinavian journal of gastroenterology 50 (1), 24-33, 2015 | 92 | 2015 |
| Epithelial TLR4 signaling activates DUOX2 to induce microbiota-driven tumorigenesis JF Burgueño, J Fritsch, EE González, KS Landau, AM Santander, ... Gastroenterology 160 (3), 797-808. e6, 2021 | 74 | 2021 |
| Differential regulation of Toll‐like receptor signalling in spleen and Peyer’s patch dendritic cells JM Davies, J MacSharry, F Shanahan Immunology 131 (3), 438-448, 2010 | 38 | 2010 |
| Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway MC Phillips, R Dheer, R Santaolalla, JM Davies, J Burgueño, JK Lang, ... Toxicology and applied pharmacology 339, 24-33, 2018 | 27 | 2018 |
| Microbial signatures and innate immune gene expression in lamina propria phagocytes of inflammatory bowel disease patients R Dheer, JM Davies, MA Quintero, OM Damas, AR Deshpande, ... Cellular and Molecular Gastroenterology and Hepatology 9 (3), 387-402, 2020 | 25 | 2020 |
| Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation JM Davies, B Sheil, F Shanahan Immunology 128 (1pt2), e805-e815, 2009 | 23 | 2009 |
| The viral mimetic polyinosinic: polycytidylic acid alters the growth characteristics of small intestinal and colonic crypt cultures JM Davies, R Santaolalla, RJ von Furstenberg, SJ Henning, MT Abreu PLoS One 10 (9), e0138531, 2015 | 21 | 2015 |
| Stool phospholipid signature is altered by diet and tumors JM Davies, HU Hua, R Dheer, M Martinez, SK Bhattacharya, MT Abreu PloS one 9 (12), e114352, 2014 | 21 | 2014 |
| Transcriptional behavior of regulatory T cells predicts IBD patient responses to vedolizumab therapy MT Abreu, JM Davies, MA Quintero, A Delmas, S Diaz, CD Martinez, ... Inflammatory bowel diseases 28 (12), 1800-1812, 2022 | 19 | 2022 |
| A nucleotide analog prevents colitis-associated cancer via beta-catenin independently of inflammation and autophagy YH Sheng, R Giri, J Davies, V Schreiber, S Alabbas, R Movva, Y He, A Wu, ... Cellular and Molecular Gastroenterology and Hepatology 11 (1), 33-53, 2021 | 19 | 2021 |
| HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR K Bisht, ME Brunck, T Matsumoto, C McGirr, B Nowlan, W Fleming, ... Blood Advances 3 (3), 406-418, 2019 | 19 | 2019 |
| Host–microbe interactions in the small bowel JM Davies, MT Abreu Current opinion in gastroenterology 31 (2), 118-123, 2015 | 15 | 2015 |
| Use of cancer stem cells to investigate the pathogenesis of colitis-associated cancer JM Davies, R Santaolalla, MT Abreu Inflammatory bowel diseases 22 (4), 976-983, 2016 | 9 | 2016 |
| MUC1-mediated macrophage activation promotes colitis-associated colorectal cancer via activating the interleukin-6/signal transducer and activator of transcription 3 axis YH Sheng, JM Davies, R Wang, KY Wong, R Giri, Y Yang, J Begun, ... Cellular and Molecular Gastroenterology and Hepatology 14 (4), 789-811, 2022 | 8 | 2022 |
| Endothelial E‑selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche‑mediated chemoresistance. Nat Commun. 2020 V Barbier, J Erbani, C Fiveash, JM Davies, J Tay, MR Tallack, J Lowe, ... DOI: https://doi. org/10.1038/s41467-020-15817-5, 2042, 0 | 8 | |
| Adhesion to E‐selectin primes macrophages for activation through AKT and mTOR JM Davies, KJ Radford, J Begun, JP Levesque, IG Winkler Immunology and Cell Biology 99 (6), 622-639, 2021 | 6 | 2021 |
| Vascular E-selectin protects leukemia cells from chemotherapy by directly activating pro-survival NF-kb Signalling-therapeutic blockade of E-selectin dampens NF-kb activation IG Winkler, V Barbier, M Ward, M Tallack, J Lowe, J Davies, J Erbani, ... Blood 128 (22), 2823, 2016 | 6 | 2016 |
